NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

KENNEDY CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000884589)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 172,931 Value ($000) $6,066 Avg Close $36.39 Range $28.19 - $42.00

Q3 2025

Shares 146,715 Value ($000) $4,173 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 13,675 Value ($000) $248 Avg Close $18.24 Range $14.06 - $22.25

Q4 2024

Shares 7,945 Value ($000) $204 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 14,046 Value ($000) $233 Avg Close $17.30 Range $15.19 - $21.48

Q2 2024

Shares 11,853 Value ($000) $228 Avg Close $20.06 Range $16.62 - $24.79

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	172,931	$6,066	$36.39	$28.19 - $42.00
Q3 2025	146,715	$4,173	$23.97	$17.97 - $28.91
Q2 2025	13,675	$248	$18.24	$14.06 - $22.25
Q4 2024	7,945	$204	$21.24	$15.51 - $27.29
Q3 2024	14,046	$233	$17.30	$15.19 - $21.48
Q2 2024	11,853	$228	$20.06	$16.62 - $24.79